Indaptus Therapeutics, Inc.
INDPNasdaqCIK 1857044HealthcareFiscal year ends Dec 31
Reports and events: 136 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2220:06 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001829126-26-011445 |
| 2026-10-2220:05 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001829126-26-011444 |
| 2026-10-2220:05 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001829126-26-011443 |
| 2026-10-2120:05 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001829126-26-011386 |
| 2026-10-2020:38 ET | 8-K | 8.01 Other events | 0001493152-26-047770 |
| 2026-09-3013:05 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-26-045040 |
| 2026-09-1001:45 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-042037 |
| 2026-09-0801:55 ET | 8-K/A | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-26-041636 |
| 2026-09-0420:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-041532 |
| 2026-09-0111:30 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-26-040926 |
| 2026-08-1311:35 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001493152-26-037579 |
| 2026-08-1311:30 ET | 8-K | 2.02 Results of operations; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-26-037574 |
| 2026-07-1620:35 ET | DEF 14A | Proxy statementPeriod 2026-07-16 | 0001493152-26-033545 |
| 2026-06-2601:40 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001829126-26-006953 |
| 2026-06-2600:00 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001829126-26-006951 |
| 2026-06-2600:00 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001829126-26-006950 |
| 2026-06-2600:00 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001829126-26-006949 |
| 2026-06-2420:01 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-029918 |
| 2026-06-0520:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-027499 |
| 2026-05-1512:15 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001493152-26-023362 |
| 2026-05-1512:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-023344 |
| 2026-04-2920:05 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001829126-26-004104 |
| 2026-04-2421:00 ET | 8-K/A | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-018954 |
| 2026-04-2301:59 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-018608 |
| 2026-04-0316:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-015079 |
| 2026-03-3001:46 ET | SCHEDULE 13D | Ownership report, active investor | 0001829126-26-002858 |
| 2026-03-2420:30 ET | 8-K | 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-012372 |
| 2026-03-2420:05 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001829126-26-002642 |
| 2026-03-1720:30 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001493152-26-010585 |
| 2026-03-0222:20 ET | SCHEDULE 13D | Ownership report, active investor | 0001829126-26-001810 |
| 2026-02-2721:05 ET | 8-K | 3.03 Change to security holders’ rights; 5.01 Change in control; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-26-008326 |
| 2026-02-1214:30 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-006330 |
| 2026-01-2122:21 ET | DEF 14A | Proxy statementPeriod 2026-01-21 | 0001493152-26-003135 |
| 2026-01-2021:06 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-002850 |
| 2026-01-0822:26 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-001004 |
| 2026-01-0221:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001493152-26-000106 |
| 2025-12-3021:01 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001493152-25-029593 |
| 2025-12-3021:01 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001493152-25-029594 |
| 2025-12-2322:22 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-25-029107 |
| 2025-11-1213:31 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001493152-25-021759 |
| 2025-11-1213:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-021758 |
| 2025-09-0420:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-012630 |
| 2025-09-0317:27 ET | S-1/A | Registration statement, amended | 0001641172-25-026333 |
| 2025-09-0213:15 ET | S-1 | Registration statement | 0001493152-25-012531 |
| 2025-08-1312:01 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001641172-25-023333 |
| 2025-08-1312:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-023332 |
| 2025-07-2920:15 ET | 8-K | 3.02 Unregistered sale of equity; 5.07 Shareholder vote results | 0001641172-25-021377 |
| 2025-07-1620:15 ET | 8-K | 8.01 Other events | 0001641172-25-019893 |
| 2025-07-0112:38 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-017283 |
| 2025-06-2621:15 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-016694 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:16 ET. Listed shows no prices and gives no investment advice.